脊髓黏液乳头型室管膜瘤的诊断与治疗

详细信息    查看全文 | 推荐本文 |

英文篇名：Diagnosis and treatment of spinal myxopapillary ependymoma 作者：周律 ; 程宏伟 ; 王先祥 ; 张义泉 ; 王晓洁 ; 王斌 ; 王卫红 ; 张科 ; 高鲁 英文作者：Zhou Lv;Cheng Hongwei;Wang Xianxiang;Zhang Yiquan;Wang Xiaojie;Wang Bin;Wang Weihong;Zhang Ke;Gao Lu;Department of Neurosurgery, First Affiliated Hospital of Anhui Medical University;Department of Pathology, First Affiliated Hospital of Anhui Medical University; 关键词：脊髓肿瘤 ; 室管膜瘤 ; 黏液乳头型 ; 入路 ; 后正中 英文关键词：spinal cord neoplasms;;ependymoma,myxopapillary;;approach,posterior median 中文刊名：ZWQX 英文刊名：Chinese Journal of Minimally Invasive Neurosurgery 机构：安徽医科大学第一附属医院神经外科;安徽医科大学第一附属医院病理科; 出版日期：2019-04-20 出版单位：中国微侵袭神经外科杂志 年：2019 期：v.24;No.227 基金：安徽省科技攻关项目(编号:12010402113) 语种：中文; 页：ZWQX201904006 页数：4 CN：04 ISSN：44-1459/R 分类号：13-16

摘要

目的探讨脊髓黏液乳头型室管膜瘤(spinal myxopapillary ependymoma,MPE)的诊断与治疗效果。方法回顾性分析9例脊髓MPE病人的临床资料,均经后正中入路手术切除肿瘤。结果肿瘤全切除8例;次全切除1例,术后行放射治疗。术后病理证实均为脊髓MPE (WHOⅠ级)。随访9例,时间3～60个月;1例出现局部转移,但无临床症状,继续随访;余8例病人无复发。结论脊髓MPE是临床少见的室管膜瘤类型,手术全切肿瘤是病人获得良好预后的主要因素,术中神经电生理监护和术中超声的运用可提高手术的安全性及全切率,无法全切的病人建议术后放疗。
        Objective To explore the diagnosis and therapeutic effect of spinal myxopapillary ependymoma(MPE). Methods Clinical data of 9 spinal MPE patients were analyzed retrospectively, who received surgery via posterior median approach. Results Total removal of the tumors was achieved in 8 patients and subtotal removal in 1 patient who received radiotherapy after surgery. The pathological result was spinal MPE(WHO grade Ⅰ). All the patients were followed up for 3 to 60 months, local metastasis was observed in 1 patient who had no clinical symptom and received continous follow-up. There was no relapse in the remaining 8 patients.Conclusions Spinal MPE is a rare type of ependymoma. Total removal of the tumor is the main important factor for a good prognosis.The safety and total resection rate can be improved by the application of intraoperative neuroelectrophysiological monitoring and intraoperative ultrasound. Postoperative radiotherapy is recommended to the subtotal removal of tumors.

引文

[1] SHIRASAWA H, ISHII K, IWANAMI A, et al. Pediatric myxopapillary ependymoma treated with subtotal resection and radiation therapy:a case report and review of the literature[J]. Spinal Cord, 2014, 52(Suppl 2):S18-S20.
    [2] BATES J E, CHOI G, MILANO M T. Myxopapillary ependymoma:a SEER analysis of epidemiology and outcomes[J]. J Neurooncol, 2016, 129(2):251-258.
    [3] BATES J E, PETERSON C R 3rd, YEANEY G A, et al.Spinal drop metastasis in myxopapillary ependymoma:a case report and a review of treatment options[J]. Rare Tumors, 2014, 6(2):5404.
    [4] FEGERL G, MAROSI C. Stabilization of metastatic myxopapillary ependymoma with sorafenib[J]. Rare Tumors,2012, 4(3):e42.
    [5] KHALATBARI M R, JALAEIKHOO H, HAMIDI M.Craniospinal dissemination of filum myxopapillary ependymoma following spinal trauma:case report and literature review[J]. Childs Nerv Syst, 2013, 29(1):149-152.
    [6] GRAF M, BLAEKER H, OTTO H F. Extraneural metastasizing ependymoma of the spinal cord[J]. Pathol Oncol Res, 1999, 5(1):56-60.
    [7] CIMINO P J, AGARWAL A, DEHNER L P. Myxopapillary ependymoma in children:a study of 11 cases and a comparison with the adult experience[J]. Pediatr Blood Cancer, 2014, 61(11):1969-1971.
    [8] REGE S V, NARAYAN S, PATIL H, et al. Spinal myxopapillary ependymoma with interval drop metastasis presenting as cauda equina syndrome:case report and review of literature[J]. J Spine Surg, 2016, 2(3):216-221.
    [9] WEBER D C, WANG Y, MILLER R, et al. Long-term outcome of patients with spinal myxopapillary ependymoma:treatment results from the MD anderson cancer center and institutions from the rare cancer network[J].Neuro Oncol, 2015, 17(4):588-595.
    [10]郝淑煜,李德志,薛湛,等.圆锥髓内病变的显微外科治疗[J].中国微侵袭神经外科杂志, 2014, 19(12):540-542.
    [11] AKYUREK S, CHANG E L, YU T K, et al. Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at MD anderson cancer center[J].J Neurooncol, 2006, 80(2):177-183.
    [12] ROSS G W, RUBINSTEIN L J. Lack of histopathological correlation of malignant ependymomas with postoperative survival[J]. J Neurosurg, 1989, 70(1):31-36.
    [13] FUJIWARA Y, MANABE H, IZUMI B, et al. Remarkable efficacy of temozolomide for relapsed spinal myxopapillary ependymoma with multiple recurrence and cerebrospinal dissemination:a case report and literature review[J]. Eur Spine J, 2018, 27(Suppl 3):421-425.
    [14] TSAI C J, WANG Y, ALLEN P K, et al. Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma:update of the MD anderson cancer center experience[J]. Neurosurgery, 2014, 75(3):205-214.
    [15] KUKREJA S, AMBEKAR S, SHARMA M, et al. Outcome predictors in the management of spinal myxopapillary ependymoma:an integrative survival analysis[J]. World Neurosurg, 2015, 83(5):852-859.
    [16] KRAETZIG T, MCLAUGHLIN L, BILSKY M H. Metastases of spinal myxopapillary ependymoma:unique characteristics and clinical management[J]. J Neurosurg Spine,2018, 28(2):201-208.